qums

Fenugreek: A therapeutic complement for patients with borderline hyperlipidemia: A randomised, double-blind, placebo-controlled, clinical trial

Yousefi, Elahe and Zareiy, Saeid and Zavoshy, Rosa and Noroozi, Mostafa and Jahanihashemi, Hassan and Ardalani, Hamidreza (2017) Fenugreek: A therapeutic complement for patients with borderline hyperlipidemia: A randomised, double-blind, placebo-controlled, clinical trial. Advances in Integrative Medicine, 4. pp. 31-35.

[img] PDF
Download (352kB)

Abstract

Objective: Fenugreek (Trigonella foenum-graecum) is a medicinal plant from Fabaceae family. This clinical study was designed to evaluate the effects of Fenugreek seeds supplementation on serum biochemical parameters of patients with borderline hyperlipidemia. Materials and methods: A randomised, double-blind, placebo-controlled clinical trial was conducted on 56 patients with borderline hyperlipidemia that were divided in two groups: F group received 8 g Fenugreek seeds powder sachets and P group received placebo sachets daily for 8 weeks. After 2 months, triglycerides (TG), total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), fasting blood glucose (FBG) and body mass index (BMI) were evaluated and compared with the baseline. Results: After 2 months, TG, TC, LDL and FBG significantly decreased in F group in comparison with P group, but these changes were not significant in HDL and BMI. Conclusion: Our findings showed that Fenugreek seeds supplementation, as a phenolic-rich herb can be effective in the reduction of some lipid profile in patients with borderline hyperlipidemia

Item Type: Article
Subjects: R Medicine > R Medicine (General)
Divisions: University Portal > research center > ktcenter
Depositing User: pr ktcenter research
Date Deposited: 23 Sep 2017 07:20
Last Modified: 23 Sep 2017 07:20
URI: http://eprints.qums.ac.ir/id/eprint/6847

Actions (login required)

View Item View Item